Flagship Gavi vaccine projects face axe if US funding stops, CEO warns

Flagship Gavi vaccine projects face axe if US funding stops, CEO warns

 31 MARCH 2025 – Some of Gavi’s flagship vaccine programmes will have to be cut if the United States goes through with a plan to stop funding the global partnership, its CEO has warned.

Among the projects under threat are plans to begin building emergency stockpiles of new mpox and tuberculosis vaccines, the distribution of badly needed malaria jabs, as well as a billion dollar programme to boost vaccine production in Africa.